Abstract
Patient-relevant bleeding events are types of bleeding or bruising that do not require medical intervention but are bothersome to patients. These events often occur as a side effect of oral anticoagulant (OAC) use in patients with atrial fibrillation (AF); however, there is currently no patient-reported outcome (PRO) measure to assess their burden on patient health-related quality of life (HRQoL) and effect on OAC adherence. This research sought to develop the Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale (ABBA-CAS), a de novo PRO measure, to fill this gap in measurement tools.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
